Your browser doesn't support javascript.
loading
Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.
Wong, Gabrielle S; Zhou, Jin; Bin Liu, Jie; Wu, Zhong; Xu, Xinsen; Li, Tianxia; Xu, David; Schumacher, Steven E; Puschhof, Jens; McFarland, James; Zou, Charles; Dulak, Austin; Henderson, Les; Xu, Peng; O'Day, Emily; Rendak, Rachel; Liao, Wei-Li; Cecchi, Fabiola; Hembrough, Todd; Schwartz, Sarit; Szeto, Christopher; Rustgi, Anil K; Wong, Kwok-Kin; Diehl, J Alan; Jensen, Karin; Graziano, Francesco; Ruzzo, Annamaria; Fereshetian, Shaunt; Mertins, Philipp; Carr, Steven A; Beroukhim, Rameen; Nakamura, Kenichi; Oki, Eiji; Watanabe, Masayuki; Baba, Hideo; Imamura, Yu; Catenacci, Daniel; Bass, Adam J.
Afiliación
  • Wong GS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Zhou J; Novartis Institutes for Biomedical Research, Inc., Cambridge, MA, USA.
  • Bin Liu J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Wu Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Xu X; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Li T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Xu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Schumacher SE; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA.
  • Puschhof J; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • McFarland J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Zou C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Dulak A; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Henderson L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Xu P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • O'Day E; Surface Oncology, Cambridge, MA, USA.
  • Rendak R; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA.
  • Liao WL; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA.
  • Cecchi F; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA.
  • Hembrough T; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA.
  • Schwartz S; OncoPlex Diagnostics/NantOmics, Rockville, MD, USA.
  • Szeto C; OncoPlex Diagnostics/NantOmics, Rockville, MD, USA.
  • Rustgi AK; OncoPlex Diagnostics/NantOmics, Rockville, MD, USA.
  • Wong KK; OncoPlex Diagnostics/NantOmics, Rockville, MD, USA.
  • Diehl JA; OncoPlex Diagnostics/NantOmics, Rockville, MD, USA.
  • Jensen K; Division of Gastroenterology, Departments of Medicine and Genetics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Graziano F; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Ruzzo A; NYU Langone Health, New York, NY, USA.
  • Fereshetian S; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
  • Mertins P; Sanofi Oncology, Cambridge, MA, USA.
  • Carr SA; University of Illinois at Urbana-Champaign, Chicago, IL, USA.
  • Beroukhim R; Department of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
  • Nakamura K; Department of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
  • Oki E; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Watanabe M; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Baba H; Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Imamura Y; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Catenacci D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bass AJ; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Nat Med ; 24(10): 1627, 2018 Oct.
Article en En | MEDLINE | ID: mdl-30093730
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos